A potential therapeutic strategy for malignant mesothelioma with gene medicine.
about
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesDevelopment of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers.Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesotheliomaTargeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.
P2860
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
@en
type
label
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
@en
prefLabel
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
@en
P2093
P2860
P921
P356
P1476
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
@en
P2093
Hideaki Shimada
Kenzo Hiroshima
Masatoshi Tagawa
P2860
P304
P356
10.1155/2013/572609
P407
P5008
P577
2013-01-16T00:00:00Z